Global Neurology Academy

Beyond the Primary Endpoint: What OCEANIC-STROKE Subtype Analyses Reveal About Asundexian’s Potential
Beyond the Primary Endpoint: What OCEANIC-STROKE Subtype Analyses Reveal About Asundexian’s Potential
Global Neurology Academy
Beyond the Primary Endpoint: What OCEANIC-STROKE Subtype Analyses Reveal About Asundexian’s Potential
- Ashkan Shoamanesh, MD
Delivering a Hopeful, Recovery-Oriented Schizophrenia Diagnosis
Delivering a Hopeful, Recovery-Oriented Schizophrenia Diagnosis
Global Neurology Academy
Delivering a Hopeful, Recovery-Oriented Schizophrenia Diagnosis
- Alexandria May, PharmD, BCPS
- Apurva Bhatt, MD
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
CME/CE Virtual Event
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
March 23, 2026
12:30 PM - 01:30 PM EDT
1.00 credit Learn more
Evaluating Structured Interventions for Cognitive Support in MS
Evaluating Structured Interventions for Cognitive Support in MS
AudioAbstracts
Evaluating Structured Interventions for Cognitive Support in MS
- Hallie Blevins, PhD
Iron Deposition and Cognitive Fatigue in Multiple Sclerosis
Iron Deposition and Cognitive Fatigue in Multiple Sclerosis
NeuroFrontiers
Iron Deposition and Cognitive Fatigue in Multiple Sclerosis
The Role of Neurofilament Light Chain in MS Management
The Role of Neurofilament Light Chain in MS Management
NeuroFrontiers
The Role of Neurofilament Light Chain in MS Management
CME/CE In-Person Event
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
May 27, 2026
May 27, 2026
Miami Beach, Florida
1.00 credit Learn more
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
CME/CE In-Person Event
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
May 27, 2026
Miami Beach, Florida
1.00 credit Learn more

Medical News

Medical News
Neuronal IDOL deletion links LDLR/APOE regulation to reduced amyloid and synaptic changes
02/16/2026
Read more
Medical News
Preclinical Insights Into CD4+ CAR-T Targeting Amyloid Beta in Alzheimer's Disease
02/13/2026
Read more
Medical News
New Findings on Visual Dysfunction in Parkinson's Disease
02/12/2026
Read more
Medical News
Understanding Parkinson’s Disease and the Brain’s Action Network
02/11/2026
Read more

See more news

CME/CE

CME/CE In-Person & Virtual Event
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
March 23, 2026
March 23, 2026
Boston, Massachusetts
1.00 credit Learn more
CME/CE In-Person Event
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
March 23, 2026
Boston, Massachusetts
1.00 credit Learn more
Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment Approach
Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment Approach
CME/CE
Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment Approach
0.25 credits
- Christyn Edmundson, MD
- Neelam Goyal, MD
0.25 credits
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
CME/CE
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
0.25 credits
- Christoph U. Correll, MD
- Jonathan M. Meyer
0.25 credits

Clinical Practice

OCEANIC-STROKE Results: Asundexian for Secondary Stroke Prevention After Acute Non-Cardioembolic Stroke or High-Risk TIA
OCEANIC-STROKE Results: Asundexian for Secondary Stroke Prevention After Acute Non-Cardioembolic Stroke or High-Risk TIA
Global Neurology Academy
OCEANIC-STROKE Results: Asundexian for Secondary Stroke Prevention After Acute Non-Cardioembolic Stroke or High-Risk TIA
- Mike Sharma, MD, MSc, FRCPC
Optimizing Vitamin D Supplementation in MS Care
Optimizing Vitamin D Supplementation in MS Care
NeuroFrontiers
Optimizing Vitamin D Supplementation in MS Care
Vitamin D3's Effects on Inflammatory and Oxidative Biomarkers in MS
Vitamin D3's Effects on Inflammatory and Oxidative Biomarkers in MS
NeuroFrontiers
Vitamin D3's Effects on Inflammatory and Oxidative Biomarkers in MS
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
NeuroFrontiers
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
- Alexandria May, PharmD, BCPS
- Michael Halassa, MD, PhD

Programs

Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
NeuroFrontiers
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
- Charles Turck, PharmD, BCPS, BCCCP
- Hannah Brown, MD
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
NeuroFrontiers
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
- Charles Turck, PharmD, BCPS, BCCCP
- Tushita Mayanil, MBBS (MD)
- Melanie Yabs, PharmD, MS, BCPP
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
NeuroFrontiers
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
- Ashley Baker, MSN, PMHNP
- Stephen Marder, MD
Identifying and Managing Violence Risk in Schizophrenia Care
Identifying and Managing Violence Risk in Schizophrenia Care
Global Neurology Academy
Identifying and Managing Violence Risk in Schizophrenia Care
- Alexandria May, PharmD, BCPS
- Ragy R. Girgis, MD, MS